Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial.
Lancet
; 381(9869): 817-24, 2013 Mar 09.
Article
em En
| MEDLINE
| ID: mdl-23312829
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Angiomiolipoma
/
Sirolimo
/
Antineoplásicos
Tipo de estudo:
Clinical_trials
/
Observational_studies
/
Risk_factors_studies
Limite:
Adult
/
Female
/
Humans
/
Male
Idioma:
En
Ano de publicação:
2013
Tipo de documento:
Article